Genética de Enfermedades Complejas
GENOME
![Foto de Genética de Enfermedades Complejas](/img/grupo.png)
![Foto de Hospital de Santa Maria](/img/noimage_org.png)
Hospital de Santa Maria
Lisboa, PortugalPublicaciones en colaboración con investigadores/as de Hospital de Santa Maria (10)
2020
-
Host immune genetic variations influence the risk of developing acute myeloid leukaemia: results from the NuCLEAR consortium
Blood Cancer Journal, Vol. 10, Núm. 7
-
NFKB2 polymorphisms associate with the risk of developing rheumatoid arthritis and response to TNF inhibitors: Results from the REPAIR consortium
Scientific Reports, Vol. 10, Núm. 1
2019
-
Correction: Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients (The Pharmacogenomics Journal, (2019), 19, 1, (83-96), 10.1038/s41397-018-0057-x)
Pharmacogenomics Journal
-
Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients
Pharmacogenomics Journal, Vol. 19, Núm. 1, pp. 83-96
-
Steroid hormone-related polymorphisms associate with the development of bone erosions in rheumatoid arthritis and help to predict disease progression: Results from the REPAIR consortium
Scientific Reports, Vol. 9, Núm. 1
2017
-
IL-10 overexpression predisposes to invasive aspergillosis by suppressing antifungal immunity
Journal of Allergy and Clinical Immunology, Vol. 140, Núm. 3, pp. 867-870.e9
2015
-
Genetic variants within immune-modulating genes influence the risk of developing rheumatoid arthritis and anti-TNF drug response: A two-stage case-control study
Pharmacogenetics and Genomics, Vol. 25, Núm. 9, pp. 432-443
-
Genetic variants within the TNFRSF1B gene and susceptibility to rheumatoid arthritis and response to anti-TNF drugs: A multicenter study
Pharmacogenetics and Genomics, Vol. 25, Núm. 7, pp. 323-333
-
TRAF1/C5 but not PTPRC variants are potential predictors of rheumatoid arthritis response to anti-tumor necrosis factor therapy
BioMed Research International, Vol. 2015